Revance Therapeu Shares Down 21.9% Since SmarTrend's Sell Call (RVNC)
October 15, 2018 at 13:38 PM EDT
SmarTrend identified a Downtrend for Revance Therapeu (NASDAQ:RVNC) on February 5th, 2018 at $30.60. In approximately 8 months, Revance Therapeu has returned 21.93% as of today's recent price of...